State TN
Clinical Trials in Tennessee
Recruiting clinical trials with at least one study location in Tennessee. Data updated daily from ClinicalTrials.gov.
Top Conditions in Tennessee
NCT07215351 N/A
Recruiting
Impact of the Inno Cleanse Dietary Supplement on Gut Health and Associated Varia...
Condition
Constipation
Enrollment
30 pts
Location
United States
Sponsor
University of Memphis
NCT04647227 Phase 4
Recruiting
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Condition
Hemophilia A With Inhibitor
Enrollment
55 pts
Location
United States
Sponsor
American Thrombosis and Hemost
NCT07122986 Phase 1
Recruiting
A Study to Learn About a Vaccine Against E Coli in Healthy Adults
Condition
Healthy Participants
Enrollment
310 pts
Location
United States
Sponsor
Pfizer
NCT06833073 Phase 2
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Ca...
Condition
Urinary Bladder Neoplasms
Enrollment
308 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06293469 N/A
Recruiting
Accelerated Flap Coverage in Severe Lower Extremity Trauma
Condition
Open Tibia Fracture
Enrollment
356 pts
Location
United States, Australia, Spain
Sponsor
Johns Hopkins University
NCT06545942 Phase 1
Recruiting
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastati...
Condition
Advanced Solid Tumor
Enrollment
220 pts
Location
United States, Spain, United Kingdom
Sponsor
MOMA Therapeutics
NCT05544266 N/A
Recruiting
Rare and Atypical Diabetes Network
Condition
Diabetes Mellitus
Enrollment
2,000 pts
Location
United States
Sponsor
University of South Florida
NCT06368817 Phase 2
Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Condition
Basal Ganglia Germinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06672510 N/A
Recruiting
Safety and Effectiveness of the Akura Thrombectomy System for Use in the Removal...
Condition
Pulmonary Embolism Acute
Enrollment
118 pts
Location
United States
Sponsor
Akura Medical
NCT05799144 Phase 2
Recruiting
pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 ...
Condition
Metastatic Oropharyngeal Carcinoma
Enrollment
54 pts
Location
United States
Sponsor
Michael K. Gibson
NCT06679140 Phase 3
Recruiting
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolesc...
Condition
COVID-19 SARS-CoV-2 Infection
Enrollment
2,330 pts
Location
United States, Argentina, Belgium
Sponsor
Pfizer
NCT07002034 Phase 2
Recruiting
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medic...
Condition
Adjustment Disorder
Enrollment
100 pts
Location
United States
Sponsor
Reunion Neuroscience Inc
NCT05904028 Phase 3
Recruiting
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascu...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
600 pts
Location
United States, Canada
Sponsor
Jaeb Center for Health Researc
NCT05887492 Phase 1, Phase 2
Recruiting
Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors
Condition
Non Small Cell Lung Cancer
Enrollment
126 pts
Location
United States
Sponsor
Tango Therapeutics, Inc.
NCT04461171 N/A
Recruiting
Enhanced Recovery After Surgery in Extremity Sarcoma
Condition
Sarcoma
Enrollment
120 pts
Location
United States
Sponsor
Joshua Lawrenz
NCT06482944 N/A
Recruiting
Whole Food for Families: A Pilot RCT of a Dietary Guidelines-Based Intervention ...
Condition
PreDiabetes
Enrollment
30 pts
Location
United States
Sponsor
Vanderbilt University
NCT05716100 Phase 3
Recruiting
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Condition
Focal Onset Seizures
Enrollment
360 pts
Location
United States, Argentina, Australia
Sponsor
Xenon Pharmaceuticals Inc.
NCT05083481 Phase 1, Phase 2
Recruiting
A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembro...
Condition
Advanced Solid Tumors
Enrollment
366 pts
Location
United States, China, France
Sponsor
Astellas Pharma Global Develop
NCT05357612 Phase 4
Recruiting
Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in...
Condition
Neurodegenerative Diseases
Enrollment
75 pts
Location
United States
Sponsor
Vanderbilt University Medical
NCT07191119 N/A
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Ch...
Condition
Survivor of Childhood Cancer
Enrollment
40 pts
Location
United States
Sponsor
St. Jude Children's Research H
NCT06667700 Phase 3
Recruiting
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Dise...
Condition
Coronavirus Disease (COVID-19)
Enrollment
3,082 pts
Location
United States, Argentina, Brazil
Sponsor
Merck Sharp & Dohme LLC
NCT01915511 N/A
Recruiting
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes...
Condition
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Enrollment
3,000 pts
Location
United States
Sponsor
Duke University
NCT05187832 Phase 1
Recruiting
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic...
Condition
Advanced or Metastatic Breast Cancer
Enrollment
61 pts
Location
United States
Sponsor
Kind Pharmaceuticals LLC
NCT05780034 Phase 1
Recruiting
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Condition
Relapsed/Refractory B-cell Malignancies
Enrollment
60 pts
Location
United States
Sponsor
Accutar Biotechnology Inc
NCT07116434 N/A
Recruiting
Discovery Diabetes
Condition
Type 1 Diabetes
Enrollment
150 pts
Location
United States
Sponsor
Vanderbilt University Medical